Le Lézard
Classified in: Health, Business
Subject: CON

Apotex Focuses on High Growth Markets with Sale of European Generics Business



Sale Part of Previously Announced Plan to Assess Global Footprint

TORONTO, July 14, 2018 /CNW/ - Apotex, Canada's largest generic pharmaceutical company, has signed an agreement to sell its commercial operations and certain supporting infrastructure for its generics business in five European countries to Aurobindo Pharma Limited.  The sale will allow Apotex to focus its resources on the Americas where strong demand for its portfolio continues.

"This is a positive move for our organization and enables us to further accelerate our efforts to drive additional growth in the Americas, while also creating manufacturing capacity to meet growing demand," said Jeff Watson, President & Chief Operating Officer, Apotex.

Apotex operates its European generic pharmaceutical business through wholly-owned subsidiaries in the Netherlands, Poland, the Czech Republic, Spain and Belgium.  Pursuant to the Agreement, these subsidiaries will be sold and certain supporting infrastructure including personnel, products, marketing authorizations and dossier license rights regarding the pharmaceutical business in those countries will effectively be transferred to Aurobindo Pharma Limited, once all closing conditions, which include customary competition clearance, are satisfied.

As part of the agreement, Apotex also entered into a transitional manufacturing and supply arrangement in order to support the ongoing growth plans of these businesses.

Apotex is a Canadian based, global pharmaceutical company, employing over 10,000 people in research, development, manufacturing and distribution facilities worldwide. Apotex is a vertically integrated business that includes generic medicines, biosimilars, active pharmaceutical ingredients and innovative pharmaceuticals. It produces more than 300 generic molecules in approximately 4,000 different dosages. For more information, please visit http://www.apotex.com

SOURCE Apotex Inc.


These press releases may also interest you

at 16:00
SAN RAFAEL, Calif., July 22, 2018 /PRNewswire-PRWeb/ -- Corporate learning is about more than checking the box. It's about engaging employees with relevant content and tools that empower them to develop their skillset. To that end, knowblytm is proud...

at 15:16
comScore today announced the official worldwide weekend box office estimates for the weekend of July 22, 2018, as compiled by the company's theatrical measurement services. As the trusted industry partner for real-time...

at 10:04
The high level of uncertainty and low level of market liquidity have made cryptocurrency investments more sensitive to market cycles, riskier to trade and more appealing to hedge funds. The bare beginning of 2018 does not scare the investors, however...

at 09:00
Carinsuranceshoppingsource.com has released a new blog post that explains where to get the best car insurance quotes online. Car insurance quotes provide prices estimates, thus helping clients select the best coverage for their needs and budget....

at 04:00
TELLURIDE, Colo., July 22, 2018 /PRNewswire-PRWeb/ -- Tueller & Gibbs, LLP, headed by Doug Tueller and Andy Gibbs, supports the transformation of this historic structure into a cultural and architectural landmark through fundraising efforts....

21 jui 2018
Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Papa John's International, Inc., and announces the filing of class action complaints against National Beverage Corp, and Farmland Partners Inc., as detailed...




News published on 14 july 2018 at 01:00 and distributed by: